186 related articles for article (PubMed ID: 22462614)
21. Imatinib-induced optic neuritis in a patient of chronic myeloid leukemia.
Govind Babu K; Attili VS; Bapsy PP; Anupama G
Int Ophthalmol; 2007 Feb; 27(1):43-4. PubMed ID: 17410337
[TBL] [Abstract][Full Text] [Related]
22. Imatinib mesylate: a new pill for chronic myelogenous leukemia.
Parmar KK; King RS
Cancer Pract; 2001; 9(5):263-5. PubMed ID: 11879324
[No Abstract] [Full Text] [Related]
23. Imatinib mesylate-induced neutrophilic folliculitis in a teenager.
García-Romero MT; Durán-McKinster C; de Ocariz MS; Carrasco-Daza D; Palacios-López C; Orozco-Covarrubias L; Ruiz-Maldonado R
Int J Dermatol; 2012 Dec; 51(12):1529-30. PubMed ID: 22486540
[No Abstract] [Full Text] [Related]
24. Hypersensitivity pneumonitis related to imatinib mesylate.
Bergeron A; Bergot E; Vilela G; Ades L; Devergie A; Espérou H; Socié G; Calvo F; Gluckman E; Ribaud P; Rousselot P; Tazi A
J Clin Oncol; 2002 Oct; 20(20):4271-2. PubMed ID: 12377975
[No Abstract] [Full Text] [Related]
25. Fatal hepatitis B virus reactivation in a chronic myeloid leukemia patient during imatinib mesylate treatment.
Ikeda K; Shiga Y; Takahashi A; Kai T; Kimura H; Takeyama K; Noji H; Ogawa K; Nakamura A; Ohira H; Sato Y; Maruyama Y
Leuk Lymphoma; 2006 Jan; 47(1):155-7. PubMed ID: 16321842
[TBL] [Abstract][Full Text] [Related]
26. [Imatinib mesylate-induced acute cytolytic hepatitis].
Rocca P; El Jastimi S; Troncy J; Scoazec JY; Boucher A; Vial T; Trépo C; Zoulim F
Gastroenterol Clin Biol; 2004 Oct; 28(10 Pt 1):918-9. PubMed ID: 15523233
[No Abstract] [Full Text] [Related]
27. Bone metabolism, growth rate and pubertal development in children with chronic myeloid leukemia treated with imatinib during puberty.
Giona F; Mariani S; Gnessi L; Moleti ML; Rea M; De Vellis A; Marzella D; Testi AM; Foà R
Haematologica; 2013 Mar; 98(3):e25-7. PubMed ID: 22983586
[No Abstract] [Full Text] [Related]
28. Bilateral cystoid macular edema in a patient with chronic myeloid leukaemia under treatment with imanitib mesylate: report of an unusual side effect.
Georgalas I; Pavesio C; Ezra E
Graefes Arch Clin Exp Ophthalmol; 2007 Oct; 245(10):1585-6. PubMed ID: 17562067
[No Abstract] [Full Text] [Related]
29. Reversible drug-induced interstitial pneumonitis following imatinib mesylate therapy.
Rajda J; Phatak PD
Am J Hematol; 2005 May; 79(1):80-1. PubMed ID: 15849772
[No Abstract] [Full Text] [Related]
30. Lack of imatinib-induced thyroid dysfunction in a cohort of non-thyroidectomized patients.
Dora JM; Leie MA; Netto B; Fogliatto LM; Silla L; Torres F; Maia AL
Eur J Endocrinol; 2008 May; 158(5):771-2. PubMed ID: 18426838
[No Abstract] [Full Text] [Related]
31. Disseminated erythematous and pityriasiform plaques caused by imatinib mesylate.
Pasmatzi E; Monastirli A; Matsouka P; Tsambaos D
Acta Derm Venereol; 2003; 83(5):391-2. PubMed ID: 14609118
[No Abstract] [Full Text] [Related]
32. Histological features of acute hepatitis after imatinib mesylate treatment.
James C; Trouette H; Marit G; Cony-Makhoul P; Mahon FX
Leukemia; 2003 May; 17(5):978-9. PubMed ID: 12750713
[No Abstract] [Full Text] [Related]
33. Renal failure associated with a specific inhibitor of BCR-ABL tyrosine kinase, STI 571.
Kitiyakara C; Atichartakarn V
Nephrol Dial Transplant; 2002 Apr; 17(4):685-7. PubMed ID: 11917072
[No Abstract] [Full Text] [Related]
34. Periungual pyogenic granuloma following imatinib therapy in a patient with chronic myelogenous leukemia.
Dika E; Barisani A; Vaccari S; Fanti PA; Ismaili A; Patrizi A
J Drugs Dermatol; 2013 May; 12(5):512-3. PubMed ID: 23652942
[No Abstract] [Full Text] [Related]
35. Acute renal failure secondary to imatinib mesylate treatment in chronic myeloid leukemia.
Pou M; Saval N; Vera M; Saurina A; Solé M; Cervantes F; Botey A
Leuk Lymphoma; 2003 Jul; 44(7):1239-41. PubMed ID: 12916879
[TBL] [Abstract][Full Text] [Related]
36. Imatinib for chronic myeloid leukaemia: a NICE mess.
Lim D; Muir J
Lancet; 2001 Dec; 358(9296):1903. PubMed ID: 11741656
[No Abstract] [Full Text] [Related]
37. Late-onset marrow aplasia due to imatinib in newly diagnosed chronic phase chronic myeloid leukaemia.
Chng WJ; Tan LH
Leuk Res; 2005 Jun; 29(6):719-20. PubMed ID: 15863215
[No Abstract] [Full Text] [Related]
38. Imatinib-associated pulmonary alveolar proteinosis.
Wagner U; Staats P; Moll R; Feek U; Vogelmeier C; Groneberg DA
Am J Med; 2003 Dec; 115(8):674. PubMed ID: 14656624
[No Abstract] [Full Text] [Related]
39. Sti571-induced Stevens-Johnson Syndrome.
Vidal D; Puig L; Sureda A; Alomar A
Br J Haematol; 2002 Oct; 119(1):274-5. PubMed ID: 12358937
[No Abstract] [Full Text] [Related]
40. Marked ploidy and BCR-ABL gene amplification in vivo in a patient treated with STI571.
Sirulink A; Silver RT; Najfeld V
Leukemia; 2001 Nov; 15(11):1795-7. PubMed ID: 11681425
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]